WEREWOLF THERAPEUTICS, INC. (HOWL) Operating cash flow 2020–2025
WEREWOLF THERAPEUTICS, INC. (HOWL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$60.3MFY2025 · since FY2020: -$18.6M → -$60.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.3M | -7.3% |
| FY2024 | -$56.2M | -72.3% |
| FY2023 | -$32.6M | +19.7% |
| FY2022 | -$40.6M | +5.3% |
| FY2021 | -$42.9M | -130.2% |
| FY2020 | -$18.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HOWL financial trends
HOWL RevenueHOWL Net incomeHOWL Net marginHOWL Gross profitHOWL Gross marginHOWL Operating incomeHOWL Operating marginHOWL Free cash flowHOWL Capital expendituresHOWL Return on equityHOWL Stock buybacksHOWL Dividends paidHOWL Total assetsHOWL Total liabilitiesHOWL Shareholders’ equityHOWL overview →